SC 13G Filing

Company

SUPERNUS PHARMACEUTICALS, INC.

Filed

May 6, 2013

Accession Number

0001214659-13-002534

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →